Expanded Access Program of Ponatinib

APPROVED_FOR_MARKETING

Conditions studied: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

In brief

This protocol will allow expanded access of ponatinib to patients ≥18 years with chronic myeloid leukemia (CML) any phase or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) who have failed all available treatment options.

Key facts

Study ID

NCT01592136

Run by

Ariad Pharmaceuticals

Last updated by the study team

2018-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Moores UCSD Cancer Center, Site #165 — La Jolla, California, United States
• Southern California Permanente Medical Group, Site #161 — San Marcos, California, United States
• Kaiser Permanente Medical Center, Site #158 — Vallejo, California, United States
• Smilow Cancer Hospital at Yale New Haven, Site #182 — New Haven, Connecticut, United States
• Cancer Institute of Florida, Site #187 — Altamonte Springs, Florida, United States
• H. Lee Moffitt Cancer Center & Research Institute, Site #017 — Tampa, Florida, United States
• Emory University, Site # 058 — Atlanta, Georgia, United States
• University of Chicago Medical Center, Site #001 — Chicago, Illinois, United States
• Indiana Blood and Marrow Transplantation, Site #138 — Indianapolis, Indiana, United States
• Norton Cancer Institute, Site #142 — Louisville, Kentucky, United States
• University of Maryland, Site #040 — Baltimore, Maryland, United States
• Tufts Medical Center, Site #141 — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute, Site 008 — Boston, Massachusetts, United States
• University of Massachusetts Worcester, Site #152 — Worcester, Massachusetts, United States
• University of Michigan Health System, Site #011 — Ann Arbor, Michigan, United States
• Karmanos Cancer Institute, Site #034 — Detroit, Michigan, United States
• Mayo Clinic, Site #044 — Rochester, Minnesota, United States
• Freeman Cancer Institute, Site #190 — Joplin, Missouri, United States
• Washington University School of Medicine, Site 007 — St Louis, Missouri, United States
• John Theurer Cancer Center at Hackensack University Medical Center, Site 128 — Hackensack, New Jersey, United States
• Roswell Park Cancer Institute, Site #029 — Buffalo, New York, United States
• Weill Cornell Medical College - New York Presbyterian Hospital, Site #006 — New York, New York, United States
• University of Rochester, Site 137 — Rochester, New York, United States
• Duke University Medical Center, Site 003 — Durham, North Carolina, United States
• Jewish Hospital, Site #175 — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.